Rupendra Shrestha

A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial

Nicholas R. Fuller, Stephen Colagiuri, Deborah Schofield et al. · International Journal of Obesity · 2012 · 2.1K citations · Full text

Pharmacy, Health Services Administration, Pharmacoeconomics +17

Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions

Tiong Yang Tan, Oliver James Dillon, Zornitza Stark et al. · JAMA Pediatrics · 2017 · 327 citations

Life Sciences, Genetics, Pediatrics +17

Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement

Zornitza Stark, Deborah Schofield, Khurshid Alam et al. · Genetics in Medicine · 2017 · 241 citations · Full text

Life Sciences, Genetics, Pharmacoeconomics +13

Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders

Lisa Ewans, Deborah Schofield, Rupendra Shrestha et al. · Genetics in Medicine · 2018 · 196 citations

Life Sciences, Genetics, Molecular Genetics +14

Chronic disease and labour force participation among older Australians

Deborah Schofield, Rupendra Shrestha, Megan Passey et al. · The Medical Journal of Australia · 2008 · 189 citations

Education, Population Health Sciences, Aging +14